A simple score to predict early death in adult cancer patients with bloodstream infections

Journal of Infection

Volumn 59, Issue 5, 2009, Pages 332-336

  Velasco, Eduardo ^a   Portugal, Rodrigo D ^b   Salluh, Jorge I F ^c  

^a Federal University of Rio de Janeiro ^*  (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Adult cancer patients; Bloodstream infections; Mortality; Predictive score model

Indexed keywords

ADULT; ARTICLE; BLOOD CULTURE; BLOODSTREAM INFECTION; BRAZIL; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTENSION; KARNOFSKY PERFORMANCE STATUS; LUNG INFECTION; LUNG INFILTRATE; MALE; NEUTROPENIA; PREDICTION; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY ANALYSIS; AGED; BACTEREMIA; DEMOGRAPHY; FUNGEMIA; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; AGED; BACTEREMIA; DEMOGRAPHY; FEMALE; FUNGEMIA; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 70449706339     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.08.009     Document Type: Article

References (24)

1. Vandijck D.M., Benoit D.D., Depuydt P.O., Offner F.C., Blot S.I., Tilborgh A.K.V., et al. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematologic malignancies. Intensive Care Med 34 5 (2008) 847-855
2. Talcott J.A., Siegel R.D., Finberg R., and Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 10 (1992) 316-322
3. Lucas K.G., Brown A.E., Armstrong D., Chapman D., and Heller Gl. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 77 (1996) 791-798
4. Castagnola E., Paola D., Giacchino R., and Viscoli C. Clinical and laboratory features predicting a favorable outcome and allowing early discharge in cancer patients with low-risk febrile neutropenia: a literature review. J Hemother Stem Cell Res 9 (2000) 645-649
5. Klastersky J., Paesmans M., Rubenstein E.B., Boyer M., Elting L., Feld R., et al. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18 (2000) 3038-3051
6. González-Barca E., Fernandez-Sevilla A., Carratalá J., Salar A., Peris J., Grañena A., et al. Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia. Eur J Clin Microbiol Infect Dis 18 (1999) 539-544
7. Velasco E., Byington R., Martins C.A.S., Schirmer M., Dias L.M.C., and Gonçalves V.M.S.C. Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center. Eur J Clin Microbiol Infect Dis 3 (2003) 137-143
8. Velasco E., Byington R., Martins C.A.S., Schirmer M., Dias L.M.C., and Gonçalves V.M.S.C. Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections. Eur J Clin Microbiol Infect Dis 25 1 (2006) 1-7
9. Read W.L., Tierney R.M., Page N.C., Costas I., Govindan R., Spitznagel E.L.J., et al. Differential prognostic impact of comorbidity. J Clin Oncol 22 (2004) 3099-3103
10. Piccirillo J.F., Tierney R.M., Costas I., Grove L., and Spitznagel Jr. E.I. Prognostic importance of comorbidity in a hospital-based cancer registry. J Am Med Assoc 291 (2004) 2441-2447
11. Velasco E., and Bigni R. A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia. Eur J Clin Infect Dis 27 (2008) 1071-1078
12. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 16 (1988) 128-140
13. Karnofsky DA, Burchenot JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLead CM (ed) Evaluation of chemotherapeutic agents. Symposium, Microbiology Section, New York Academy of Medicine, New York, NY, 1948. Columbia University Press, New York, 1949.
14. World Health Organization. Handbook for reporting results of cancer treatment (1979), WHO, Geneva
15. Johnston A.S., Piccirillo J.F., Creech C., Littenberg B., Jeffe D., and Spitznagel E.L. Validation of a comorbidity education program. J Registry Manage 28 (2001) 125-131
16. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating (ROC) curve. Radiology 143 (1982) 29-36
17. Lemeshow S., and Hosmer D.W.J. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115 (1982) 92-106
18. Laupacis A., Sekar N., and Stiell I.G. Clinical prediction rules: a review and suggested modifications of methodological standards. J Am Med Assoc 277 (1997) 488-494
19. Benoit D.D., Vandewoude K.H., Decruyenaere J.M., Hoste E.A., and Colardyn F.A. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 31 (2003) 104-112
20. Soares M., and Salluh J.I. Validation of the SAPS 3 admission prognostic model in patients with cancer in need of intensive care. Intensive Care Med 32 (2006) 1839-1844
21. Blot F., Cordonnier C., Buzin A., Nitenberg G., Schlemmer B., and Bastuji-Garin S. Club sur L'Infection en Onco-Hématologie. Severity of illness scores: are they useful in febrile neutropenic adult patients in hematology wards? A prospective multicenter study. Crit Care Med 29 (2001) 2125-2131
22. Talcott J.A., Whalen A., Clark J., Rieker P.P., and Finberg R. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 12 (1994) 107-114
23. Innes H., Lim S.L., Hall A., Chan S.Y., Bhalla N., and Marshall E. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice. Support Care Cancer 16 (2008) 485-491
24. Vales E.C., Abraira V., Sánchez J.C.C., Garcia M.P.A., Feijoo A.R., Alvareza M.J.L., et al. A predictive model for mortality of bloodstream infections: bedside analysis with the Weibull function. J Clin Epidemiol 55 (2002) 563-572